Koyfin Home > Directory > Health Care > Acceleron Pharma > Long-Term Investments

Acceleron Pharma Long-Term Investments Chart (XLRN)

Acceleron Pharma annual/quarterly Long-Term Investments from 2015 to 2020.
  • Acceleron Pharma Long-Term Investments for the quarter ending March 03, 2020 was $1m a -6,147.20% decrease of -69m year over year
  • Acceleron Pharma Long-Term Investments for the last 12 months ending March 03, 2020 was $1m a -6,147.20% decrease of -69m year over year
  • Acceleron Pharma Annual Long-Term Investments for 2019 was $22m a -325.87% decrease of -73m from 2018
  • Acceleron Pharma Annual Long-Term Investments for 2017 was $96m a 1.08% increase of 1m from 2016
  • Acceleron Pharma Annual Long-Term Investments for 2016 was $95m a 67.12% increase of 64m from 2015
Other Cash Flow Metrics:
  • Acceleron Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-29m a 19.28% decrease of -6m year over year
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-41m a 62.43% decrease of -26m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Long-Term Investments Data

03/2020$1m
12/2019$22m
09/2019$42m
06/2019$70m
03/2019$76m
09/2018$12m
06/2018$44m
03/2018$61m
12/2017$96m
09/2017$29m

Annual XLRN Long-Term Investments Data

2019$22m
2017$96m
2016$95m
2015$31m